ID: ALA3221944

Max Phase: Preclinical

Molecular Formula: C11H8FNO2S

Molecular Weight: 237.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)/C(S)=C/c1c[nH]c2c(F)cccc12

Standard InChI:  InChI=1S/C11H8FNO2S/c12-8-3-1-2-7-6(5-13-10(7)8)4-9(16)11(14)15/h1-5,13,16H,(H,14,15)/b9-4-

Standard InChI Key:  PVCOGASVAVBZOY-WTKPLQERSA-N

Associated Targets(non-human)

Calpain 1 219 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 237.25Molecular Weight (Monoisotopic): 237.0260AlogP: 2.66#Rotatable Bonds: 2
Polar Surface Area: 53.09Molecular Species: ACIDHBA: 2HBD: 3
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.68CX Basic pKa: CX LogP: 2.37CX LogD: -0.67
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.56Np Likeness Score: -0.60

References

1. Adams SE, Parr C, Miller DJ, Allemann RK, Hallett MB.  (2012)  Potent inhibition of Ca2+-dependent activation of calpain-1 by novel mercaptoacrylates,  (5): [10.1039/C2MD00280A]

Source